loading

Pds Biotechnology Corporation Stock (PDSB) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
2.97%
10.10
10.41 10.52 12.70 9.4224
Interest Income/Expense
0.00%
1.1747
1.1748 1.0689 0.9954 0.9668
Operating Income/Loss
2.97%
-10.10
-10.41 -10.52 -12.70 -9.4224
Income/Loss From Continuing Operations Before Tax
2.70%
-10.60
-10.90 -10.85 -12.94 -9.6599
Income Tax Expense/Benefit, Current
-
- - - -
Income/Loss From Continuing Operations After Tax
2.70%
-10.60
-10.90 -10.85 -11.53 -9.6599
Net Income/Loss
2.70%
-10.60
-10.90 -10.85 -11.53 -9.6599
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
14,615%
34.82
0.2366 30.91 30.80 30.43
Diluted Average Shares
14,615%
34.82
0.2366 30.91 30.80 30.43
Basic Earnings Per Share
14.29%
-0.30
-0.35 -0.35 -0.37 -0.32
Diluted Earnings Per Share
14.29%
-0.30
-0.35 -0.35 -0.37 -0.32
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.94
price down icon 1.35%
$75.45
price up icon 0.87%
$43.39
price up icon 3.19%
$378.13
price up icon 0.30%
$206.16
price up icon 7.31%
$120.72
price up icon 1.84%
Cap:     |  Volume (24h):